TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pro Medicus Limited ( (AU:PME) ) has shared an update.
Pro Medicus Limited announced a change in the director’s interest, with Dr. Sam Aaron Hupert acquiring 50,000 ordinary shares through an off-market transfer. This transfer, valued at $299 per share, increases Dr. Hupert’s total holdings to 24,187,660 shares, reflecting a strategic move in consolidating his stake in the company.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$350.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, providing advanced imaging software and services. The company focuses on delivering innovative solutions for medical imaging and healthcare IT, catering to hospitals and healthcare providers.
Average Trading Volume: 174,402
Technical Sentiment Signal: Buy
Current Market Cap: A$31.23B
For an in-depth examination of PME stock, go to TipRanks’ Overview page.